Studies of the antineoplastic activity and metabolism of  -(N)-heterocyclic carboxaldehyde thiosemicarbazones in dogs and mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001711:Biotransformation; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002852:Chromatography, Ion Exchange; D002855:Chromatography, Thin Layer; D004285:Dogs; D005753:Gastric Mucosa / Q000378:metabolism; D005965:Glucuronates / Q000652:urine; D007413:Intestinal Mucosa / Q000378:metabolism; D007546:Isoquinolines / Q000378:metabolism / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000517:prevention & control*; D051379:Mice; D012513:Sarcoma, Experimental; D013460:Sulfur Isotopes; D013882:Thiosemicarbazones / Q000378:metabolism / Q000494:pharmacology*
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D005965:Glucuronates; D007546:Isoquinolines; D013460:Sulfur Isotopes; D013882:Thiosemicarbazones; D002245:Carbon Dioxide